UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Signaling pathways essential for triple‐negative breast cancer stem‐like cells

Stem cells (Dayton, Ohio), 2021-02, Vol.39 (2), p.133-143

2021

Volltextzugriff (PDF)

Fyn is an important molecule in cancer pathogenesis and drug resistance

Pharmacological research, 2015-10, Vol.100, p.250-254

2015

Volltextzugriff (PDF)

Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer

Cancer cell, 2021-08, Vol.39 (8), p.1034-1036

2021

Volltextzugriff (PDF)

Oncogenic cancer/testis antigens: prime candidates for immunotherapy

Oncotarget, 2015-06, Vol.6 (18), p.15772-15787

2015

Volltextzugriff (PDF)

Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer

International journal of molecular sciences, 2023-02, Vol.24 (5), p.4522

2023

Volltextzugriff (PDF)

Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome

Cell reports (Cambridge), 2019-06, Vol.27 (13), p.3927-3938.e6

2019

Volltextzugriff (PDF)

Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy

Nature communications, 2022-07, Vol.13 (1), p.4118-4118, Article 4118

2022

Volltextzugriff (PDF)

HMGA2 as a Critical Regulator in Cancer Development

Genes, 2021-02, Vol.12 (2), p.269

2021

Volltextzugriff (PDF)

De novo pathway-based biomarker identification

Nucleic acids research, 2017-09, Vol.45 (16), p.e151-e151

2017

Volltextzugriff (PDF)

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer

Nature communications, 2017-09, Vol.8 (1), p.410-14, Article 410

2017

Volltextzugriff (PDF)

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC

JNCI : Journal of the National Cancer Institute, 2017-09, Vol.109 (9)

2017

Volltextzugriff (PDF)

Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence

Nature medicine, 2017-11, Vol.23 (11), p.1319-1330

2017

Volltextzugriff (PDF)

Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study

PloS one, 2012-05, Vol.7 (5), p.e36170-e36170

2012

Volltextzugriff (PDF)

Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2

Cell death and differentiation, 2019-02, Vol.26 (2), p.276-290

2019

Volltextzugriff (PDF)

Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer

International journal of molecular sciences, 2022-09, Vol.23 (17), p.10053

2022

Volltextzugriff (PDF)

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Nature communications, 2021-08, Vol.12 (1), p.5112-5112, Article 5112

2021

Volltextzugriff (PDF)

EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy

Nature communications, 2020-11, Vol.11 (1), p.5878-5878, Article 5878

2020

Volltextzugriff (PDF)

Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer

Cancer cell, 2022-08, Vol.40 (8), p.800-801

2022

Volltextzugriff (PDF)

PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer

Cancers, 2022-12, Vol.14 (24), p.6153

2022

Volltextzugriff (PDF)

SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer

Breast cancer research : BCR, 2018-06, Vol.20 (1), p.60-60, Article 60

2018

Volltextzugriff (PDF)

Human DREF/ZBED1 is a nuclear protein widely expressed in multiple cell types derived from all three primary germ layers

PloS one, 2018-10, Vol.13 (10), p.e0205461-e0205461

2018

Volltextzugriff (PDF)

Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer

Clinical cancer research, 2015-06, Vol.21 (11), p.2635-2643

2015

Volltextzugriff (PDF)

Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells

The Journal of immunology (1950), 2013-10, Vol.191 (8), p.4165-4173

2013

Volltextzugriff (PDF)

Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker Discovery

Molecular & cellular proteomics, 2010-07, Vol.9 (7), p.1369-1382

2010

Volltextzugriff (PDF)

1 – 25 von 248

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(218)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Signaling pathways essential for triple‐negative breast cancer stem‐like cells

Fyn is an important molecule in cancer pathogenesis and drug resistance

Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer

Oncogenic cancer/testis antigens: prime candidates for immunotherapy

Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer

Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome

Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy

HMGA2 as a Critical Regulator in Cancer Development

De novo pathway-based biomarker identification

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC

Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence

Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study

Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2

Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy

Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer

PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer

SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer

Human DREF/ZBED1 is a nuclear protein widely expressed in multiple cell types derived from all three primary germ layers

Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer

Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells

Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker Discovery

Suchergebnisse filtern